Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jan 14;20(1):10.
doi: 10.1186/s12876-020-1165-z.

Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis

Xuefeng Ma  1 , Shousheng Liu  2   3 , Jie Zhang  1 , Mengzhen Dong  1 , Yifen Wang  1 , Mengke Wang  1 , Yongning Xin  4   5
Affiliations
Meta-Analysis

Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis

Xuefeng Ma et al. BMC Gastroenterol. .

Abstract

Background: ALT value is often used to reflect the hepatic inflammation and injury in NAFLD patients, but many studies proved that ALT values were normal in many NAFLD patients. The aim of this study was to identify the summarized proportion of NAFLD patients with normal ALT value in the overall NAFLD patients.

Methods: Electronic databases PubMed, EMBASE, Ovid, and the Cochrane Library were searched for potential studies published from January 1, 2000 to September 30, 2019. Studies that have reported the number of NAFLD or NASH patients with normal and abnormal ALT value were included and analyzed. Abstracts, reviews, case reports, and letters were excluded.

Results: A total of 11 studies with 4084 patients were included for assessing the summarized proportion of NAFLD patients with normal ALT in overall NAFLD patients. As the results shown, the summarized proportion of NAFLD patients with normal ALT value in overall NAFLD patients was 25% (95%CI: 20-31%) which was calculated by the random-effects model. The summarized proportion of NASH patients with normal ALT value in overall NASH patients was 19% (95%CI: 13-27%). Subgroup analysis includes region, study type, diagnostic method, and group size were conducted to investigate the resource of heterogeneity in the summarized proportion of NAFLD and NASH patients with normal ALT value.

Conclusions: 25% NAFLD patients and 19% NASH patients possess the normal ALT value in the clinical manifestation. The value of ALT in the clinical diagnosis of NAFLD and NASH remains need be further testified.

Keywords: ALT; Meta-analysis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any disclosures to report.

Figures

Fig. 1
Fig. 1
Flow chart of the literature search process
Fig. 2
Fig. 2
Summarized proportion of NAFLD patients with normal ALT value in overall NAFLD patients
Fig. 3
Fig. 3
Funnel plot of publication bias on the proportion of NAFLD patients with normal ALT value
Fig. 4
Fig. 4
Summarized proportion of NASH patients with normal ALT value in overall NASH patients
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862–873. doi: 10.1016/j.jhep.2017.06.003. - DOI - PubMed
    1. Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69:896–904. doi: 10.1016/j.jhep.2018.05.036. - DOI - PubMed
    1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20. doi: 10.1038/nrgastro.2017.109. - DOI - PubMed
    1. Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389–398. doi: 10.1016/S2468-1253(19)30039-1. - DOI - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023. doi: 10.1002/hep.25762. - DOI - PubMed

Substances